STTK (STOCKS)
Shattuck Labs, Inc. Common Stock
$6.770000
-0.150000 (-2.17%)
Prev close: $6.920000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Taylor H. Schreiber
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $483.77M
- Employees
- 44
- P/E (TTM)
- -8.75
- P/B (TTM)
- 5.31
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.00M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $52.51M |
| Nonoperating Income/Loss | $2.70M |
| Operating Expenses | $52.51M |
| Research and Development | $35.27M |
| Other Operating Expenses | $17.24M |
| Operating Income/Loss | -$51.51M |
| Income/Loss From Continuing Operations After Tax | -$48.81M |
| Income/Loss From Continuing Operations Before Tax | $1.00M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$48.81M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$48.81M |
| Net Income/Loss Available To Common Stockholders, Basic | -$48.81M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.70 |
| Diluted Earnings Per Share | -$0.70 |
| Basic Average Shares | 69,584,937 |
| Diluted Average Shares | 69,584,937 |
| Assets | $91.03M |
| Current Assets | $82.48M |
| Cash | $78.10M |
| Other Current Assets | $4.38M |
| Noncurrent Assets | $8.55M |
| Fixed Assets | $6.11M |
| Other Non-current Assets | $2.44M |
| Liabilities | $8.64M |
| Current Liabilities | $7.05M |
| Accounts Payable | $2.10M |
| Wages | $2.77M |
| Other Current Liabilities | $2.18M |
| Noncurrent Liabilities | $1.58M |
| Equity | $82.39M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $82.39M |
| Liabilities And Equity | $91.03M |
| Net Cash Flow From Operating Activities | -$39.88M |
| Net Cash Flow From Operating Activities, Continuing | -$39.88M |
| Net Cash Flow From Investing Activities | -$7.89M |
| Net Cash Flow From Investing Activities, Continuing | -$7.89M |
| Net Cash Flow From Financing Activities | $44.57M |
| Net Cash Flow From Financing Activities, Continuing | $44.57M |
| Net Cash Flow | -$3.20M |
| Net Cash Flow, Continuing | -$3.20M |
| Comprehensive Income/Loss | -$48.81M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$48.81M |
| Other Comprehensive Income/Loss | -$48.81M |